| scholarly article | Q13442814 |
| P50 | author | Adam D Richardson | Q55130332 |
| Gary G. Chiang | Q55130333 | ||
| Fabian V. Filipp | Q55130334 | ||
| P2093 | author name string | David A Scott | |
| Ze'ev A Ronai | |||
| Jeffrey W Smith | |||
| Andrei L Osterman | |||
| Christine A Knutzen | |||
| P2860 | cites work | Main roads to melanoma | Q21245465 |
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate | Q24605258 | ||
| GeneCards Version 3: the human gene integrator | Q24610308 | ||
| Cluster analysis and display of genome-wide expression patterns | Q24644463 | ||
| Human melanoma cells express functional receptors for thyroid-stimulating hormone | Q79422393 | ||
| HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia | Q28300406 | ||
| HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption | Q28300415 | ||
| Metabolic profiling of hypoxic cells revealed a catabolic signature required for cell survival | Q28476795 | ||
| Java Treeview--extensible visualization of microarray data | Q29547226 | ||
| Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity | Q29616651 | ||
| On respiratory impairment in cancer cells | Q29617276 | ||
| Otto Warburg's contributions to current concepts of cancer metabolism | Q29617601 | ||
| Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis | Q29617613 | ||
| The impact of O2 availability on human cancer | Q29619884 | ||
| Determination of metabolic flux ratios from 13C-experiments and gas chromatography-mass spectrometry data: protocol and principles | Q31065954 | ||
| Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer | Q33604129 | ||
| Quiescent fibroblasts exhibit high metabolic activity. | Q33737849 | ||
| A role for ATF2 in regulating MITF and melanoma development | Q33784589 | ||
| Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review | Q34028478 | ||
| Deletion of genes encoding cytochrome oxidases and quinol monooxygenase blocks the aerobic-anaerobic shift in Escherichia coli K-12 MG1655. | Q34177720 | ||
| Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells | Q34517790 | ||
| Hypoxia, melanocytes and melanoma - survival and tumor development in the permissive microenvironment of the skin | Q34570988 | ||
| Molecular imaging of cancer with positron emission tomography | Q34810431 | ||
| Pyruvate carboxylase is required for glutamine-independent growth of tumor cells | Q35008346 | ||
| Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth | Q35458543 | ||
| Phosphatidylinositol-3-kinase as a therapeutic target in melanoma | Q35606261 | ||
| Central carbon metabolism in the progression of mammary carcinoma | Q36738269 | ||
| Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression | Q37042015 | ||
| Evidence for reverse flux through pyruvate kinase in skeletal muscle. | Q37162296 | ||
| Melanoma: molecular pathogenesis and emerging target therapies (Review). | Q37474412 | ||
| Rethinking the Warburg effect with Myc micromanaging glutamine metabolism | Q37677940 | ||
| Targeting metabolic transformation for cancer therapy. | Q37714309 | ||
| Targeting cancer metabolism: a therapeutic window opens | Q37924094 | ||
| C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells | Q39954044 | ||
| Quantifying reductive carboxylation flux of glutamine to lipid in a brown adipocyte cell line | Q39998829 | ||
| Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells | Q40007880 | ||
| Comparative metabolomics of breast cancer. | Q40054731 | ||
| Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors | Q40444060 | ||
| Cellular senescence in naevi and immortalisation in melanoma: a role for p16? | Q42016240 | ||
| Ammonia derived from glutaminolysis is a diffusible regulator of autophagy | Q42470786 | ||
| Correcting mass isotopomer distributions for naturally occurring isotopes | Q44153792 | ||
| Mechanistic stoichiometry of mitochondrial oxidative phosphorylation | Q45036631 | ||
| Acylic sugar derivatives for GC/MS analysis of 13C-enrichment during carbohydrate metabolism | Q45147529 | ||
| Measurement of fractional lipid synthesis using deuterated water (2H2O) and mass isotopomer analysis | Q46583121 | ||
| P433 | issue | 49 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | flux | Q5463013 |
| P304 | page(s) | 42626-42634 | |
| P577 | publication date | 2011-10-13 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect | |
| P478 | volume | 286 |
| Q37004918 | (13)C MRS and LC-MS Flux Analysis of Tumor Intermediary Metabolism |
| Q38710762 | 2-Methoxyestradiol enhances radiosensitivity in radioresistant melanoma MDA-MB-435R cells by regulating glycolysis via HIF-1α/PDK1 axis |
| Q89791834 | A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965 |
| Q42269519 | A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds |
| Q37326607 | Activated lymphocytes as a metabolic model for carcinogenesis. |
| Q38439387 | Activity-Based Protein Profiling Shows Heterogeneous Signaling Adaptations to BRAF Inhibition |
| Q91792367 | Aerobic glycolysis and high level of lactate in cancer metabolism and microenvironment |
| Q28834138 | Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration |
| Q38961789 | Altered metabolite levels in cancer: implications for tumour biology and cancer therapy. |
| Q55091781 | Amino Acid Signature in Human Melanoma Cell Lines from Different Disease Stages. |
| Q60709661 | Analysis of biologically-active, endogenous carboxylic acids based on chromatography-mass spectrometry |
| Q50020665 | Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model. |
| Q36421268 | Application of Collagen-Model Triple-Helical Peptide-Amphiphiles for CD44-Targeted Drug Delivery Systems |
| Q35856331 | Arginylation regulates purine nucleotide biosynthesis by enhancing the activity of phosphoribosyl pyrophosphate synthase |
| Q55474292 | BCL2 and BCL(X)L selective inhibitors decrease mitochondrial ATP production in breast cancer cells and are synthetically lethal when combined with 2-deoxy-D-glucose. |
| Q35836409 | BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume |
| Q60960586 | Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomas |
| Q36650340 | Bonded Cumomer Analysis of Human Melanoma Metabolism Monitored by 13C NMR Spectroscopy of Perfused Tumor Cells |
| Q37102798 | Cancer metabolism meets systems biology: Pyruvate kinase isoform PKM2 is a metabolic master regulator. |
| Q24698579 | CeCaFDB: a curated database for the documentation, visualization and comparative analysis of central carbon metabolic flux distributions explored by 13C-fluxomics |
| Q35915928 | Cellular metabolism and disease: what do metabolic outliers teach us? |
| Q36570461 | Characterisation of bioenergetic pathways and related regulators by multiple assays in human tumour cells. |
| Q37019550 | Chemical approaches to study metabolic networks |
| Q42152710 | Chemotherapy regimen based on sorafenib combined with 5-FU on HIF-1α and VEGF expression and survival in advanced gastric cancer patients |
| Q36812466 | Cofactor balance by nicotinamide nucleotide transhydrogenase (NNT) coordinates reductive carboxylation and glucose catabolism in the tricarboxylic acid (TCA) cycle |
| Q93109246 | Concurrent Targeting of Glutaminolysis and Metabotropic Glutamate Receptor 1 (GRM1) Reduces Glutamate Bioavailability in GRM1+ Melanoma |
| Q58708143 | Cytochrome C oxidase Inhibition and Cold Plasma-derived Oxidants Synergize in Melanoma Cell Death Induction |
| Q38919337 | Cytotoxic mechanisms of panduratin A on A375 melanoma cells: A quantitative and temporal proteomics analysis |
| Q41458701 | Discovery of potential biomarkers in human melanoma cells with different metastatic potential by metabolic and lipidomic profiling |
| Q35665565 | Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway |
| Q90227500 | Diverse Roads Taken by 13C-Glucose-Derived Metabolites in Breast Cancer Cells Exposed to Limiting Glucose and Glutamine Conditions |
| Q37038401 | Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the (V600E)BRAF oncogene. |
| Q26784630 | Dysregulated metabolism contributes to oncogenesis |
| Q96640459 | ERK signalling: a master regulator of cell behaviour, life and fate |
| Q33608219 | Emerging Metabolic Therapies in Pulmonary Arterial Hypertension |
| Q38066202 | Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review). |
| Q36611096 | Establishment of human iPSC-based models for the study and targeting of glioma initiating cells |
| Q90703406 | Evaluation of integrin αvβ6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis |
| Q42572928 | Exploiting tumor metabolism: challenges for clinical translation |
| Q89989601 | FOXO3a‑SIRT6 axis suppresses aerobic glycolysis in melanoma |
| Q43781559 | Fatty acid synthase plays a role in cancer metabolism beyond providing fatty acids for phospholipid synthesis or sustaining elevations in glycolytic activity. |
| Q28118829 | Functional specialization in proline biosynthesis of melanoma |
| Q27004739 | Genetically-defined metabolic reprogramming in cancer |
| Q38064856 | Germ cell proteins in melanoma: prognosis, diagnosis, treatment, and theories on expression |
| Q36516956 | Global profiling strategies for mapping dysregulated metabolic pathways in cancer |
| Q90074895 | Glucose Exerts an Anti-Melanogenic Effect by Indirect Inactivation of Tyrosinase in Melanocytes and a Human Skin Equivalent |
| Q37622642 | Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation. |
| Q42406273 | Glutamate and asparagine cataplerosis underlie glutamine addiction in melanoma |
| Q27011818 | Glutamine and cancer: cell biology, physiology, and clinical opportunities |
| Q38933788 | Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. |
| Q36330223 | Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma. |
| Q38030652 | Glutamine-fueled mitochondrial metabolism is decoupled from glycolysis in melanoma. |
| Q93187619 | HSF1: a mediator in metabolic alteration of hepatocellular carcinoma cells in cross-talking with tumor-associated macrophages |
| Q39133952 | HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer |
| Q64280878 | Human macular Müller cells rely more on serine biosynthesis to combat oxidative stress than those from the periphery |
| Q36155710 | Human milk oligosaccharides promote the growth of staphylococci. |
| Q28081811 | Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters |
| Q35920909 | Hypoxia-Mediated Increases in L-2-hydroxyglutarate Coordinate the Metabolic Response to Reductive Stress |
| Q36948088 | IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism |
| Q39264242 | Importance of glycolysis and oxidative phosphorylation in advanced melanoma |
| Q38821977 | Influence of Serum and Hypoxia on Incorporation of [(14)C]-D-Glucose or [(14)C]-L-Glutamine into Lipids and Lactate in Murine Glioblastoma Cells. |
| Q48544710 | Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin. |
| Q36771980 | Inhibition of the pentose phosphate pathway by dichloroacetate unravels a missing link between aerobic glycolysis and cancer cell proliferation. |
| Q26771751 | Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics |
| Q51735722 | Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects. |
| Q42850122 | L-Proline induces a mesenchymal-like invasive program in embryonic stem cells by remodeling H3K9 and H3K36 methylation |
| Q45258948 | L-Proline uptake in Saccharomyces cerevisiae mitochondria can contribute to bioenergetics during nutrient stress as alternative mitochondrial fuel. |
| Q47557123 | Long non-coding RNA H19 promotes glucose metabolism and cell growth in malignant melanoma via miR-106a-5p/E2F3 axis. |
| Q38130258 | Mapping cancer cell metabolism with(13)C flux analysis: Recent progress and future challenges |
| Q55314550 | Mass Spectrometry-Based Method to Study Inhibitor-Induced Metabolic Redirection in the Central Metabolism of Cancer Cells. |
| Q90043581 | Melanoma Metabolism: Cell Survival and Resistance to Therapy |
| Q64059069 | Melanoma proteomics suggests functional differences related to mutational status |
| Q97525205 | Metabolic Adaptations in Cancer Stem Cells |
| Q96304654 | Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment |
| Q36413347 | Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival |
| Q41831762 | Metabolic and bactericidal effects of targeted suppression of NadD and NadE enzymes in mycobacteria. |
| Q28082949 | Metabolic consequences of oncogenic IDH mutations |
| Q26795759 | Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication |
| Q47401579 | Metabolic phenotyping of CHO cells varying in cellular biomass accumulation and maintenance during fed-batch culture |
| Q37131345 | Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation |
| Q28069081 | Metabolic rewiring in melanoma |
| Q47759599 | Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications. |
| Q47269342 | Metabolic stress regulates ERK activity by controlling KSR-RAF heterodimerization |
| Q38280740 | Metabolism and epigenetics: a link cancer cells exploit. |
| Q36108056 | Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming |
| Q58728932 | Metformin: Focus on Melanoma |
| Q38801510 | MicroRNA 211 Functions as a Metabolic Switch in Human Melanoma Cells |
| Q38332527 | Mitochondria as biosynthetic factories for cancer proliferation. |
| Q102141808 | Mitochondrial oxidative phosphorylation in cutaneous melanoma |
| Q37420174 | Mitochondrial oxidative stress is the Achille's heel of melanoma cells resistant to Braf-mutant inhibitor |
| Q28482377 | Mitochondrial respiration--an important therapeutic target in melanoma |
| Q36733029 | Mitochondrial uncoupling and the reprograming of intermediary metabolism in leukemia cells |
| Q38043052 | Mitophagy or how to control the Jekyll and Hyde embedded in mitochondrial metabolism: implications for melanoma progression and drug resistance |
| Q38716429 | NMR metabolic fingerprints of murine melanocyte and melanoma cell lines: application to biomarker discovery |
| Q40417423 | Natural isotope correction of MS/MS measurements for metabolomics and (13)C fluxomics. |
| Q27005930 | Novel therapeutic targets of tumor metabolism |
| Q60050766 | Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells |
| Q47159555 | Oncogene-Driven Metabolic Alterations in Cancer |
| Q37395416 | Oncogene-directed alterations in cancer cell metabolism |
| Q33551699 | Organochloride pesticides impaired mitochondrial function in hepatocytes and aggravated disorders of fatty acid metabolism |
| Q37260512 | Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells |
| Q38874710 | Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy. |
| Q36579595 | Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications |
| Q37742635 | Precision medicine driven by cancer systems biology |
| Q48150110 | Prediction of enzymatic pathways by integrative pathway mapping. |
| Q41989445 | Press-pulse: a novel therapeutic strategy for the metabolic management of cancer. |
| Q91755813 | Prioritization and comprehensive analysis of genes associated with melanoma |
| Q92782850 | Pro-inflammatory macrophages coupled with glycolysis remodel adipose vasculature by producing platelet-derived growth factor-B in obesity |
| Q33877459 | Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation. |
| Q36310230 | Proline biosynthesis augments tumor cell growth and aerobic glycolysis: involvement of pyridine nucleotides |
| Q36203215 | Proline dehydrogenase is essential for proline protection against hydrogen peroxide-induced cell death |
| Q35662444 | Pyruvate Carboxylase Is Up-Regulated in Breast Cancer and Essential to Support Growth and Invasion of MDA-MB-231 Cells |
| Q42211295 | ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells |
| Q34710980 | Regulation of substrate utilization by the mitochondrial pyruvate carrier |
| Q36476849 | Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells |
| Q35897562 | Reverse TCA cycle flux through isocitrate dehydrogenases 1 and 2 is required for lipogenesis in hypoxic melanoma cells |
| Q43242538 | Right on TARGET: glutamine metabolism in cancer |
| Q37617965 | Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer |
| Q47549487 | Roles of pyruvate carboxylase in human diseases: from diabetes to cancers and infection |
| Q26852150 | Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study |
| Q35899174 | Suppression of PGC-1α Is Critical for Reprogramming Oxidative Metabolism in Renal Cell Carcinoma |
| Q35209056 | TRIM24 links glucose metabolism with transformation of human mammary epithelial cells |
| Q89983816 | Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition |
| Q36905724 | Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest |
| Q57462443 | Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival |
| Q38739247 | The BRAF Inhibitor Vemurafenib Activates Mitochondrial Metabolism and Inhibits Hyperpolarized Pyruvate-Lactate Exchange in BRAF-Mutant Human Melanoma Cells |
| Q93054548 | The Complex Role of Autophagy in Melanoma Evolution: New Perspectives From Mouse Models |
| Q37656478 | The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics. |
| Q92918403 | The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism |
| Q37068082 | The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4 |
| Q37622584 | The metabolic origins of mannose in glycoproteins |
| Q53103335 | The metabolomics of psoriatic disease. |
| Q43004555 | Time-resolved fluorescence lifetime for cutaneous melanoma detection. |
| Q35932960 | Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells. |
| Q36602677 | Understanding metabolic regulation and its influence on cell physiology |
| Q37457989 | Upregulation of glycolysis and oxidative phosphorylation in benzo[α]pyrene and arsenic-induced rat lung epithelial transformed cells |
| Q46357034 | Using [U-(13)C(6)]-Glucose Tracer to Study Metabolic Changes in Oncogene-Induced Senescence Fibroblasts |
| Q88090187 | VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation |
| Q39123491 | VDAC-Tubulin, an Anti-Warburg Pro-Oxidant Switch |
| Q39841623 | Vitamin K3 induces antiproliferative effect in cervical epithelial cells transformed by HPV 16 (SiHa cells) through the increase in reactive oxygen species production. |
| Q90208059 | Wild-Type IDH Enzymes as Actionable Targets for Cancer Therapy |
Search more.